Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.700
-0.220 (-7.53%)
At close: Apr 28, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
Pre-market: Apr 29, 2026, 7:31 AM EDT

BDTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
15513812114565193
Upgrade
Market Cap Growth
96.39%14.33%-16.54%121.66%-66.10%-83.26%
Upgrade
Enterprise Value
45233127-50-13
Upgrade
Last Close Price
2.702.432.142.811.805.33
Upgrade
PE Ratio
6.926.19----
Upgrade
PS Ratio
2.211.98----
Upgrade
PB Ratio
1.371.231.451.240.570.99
Upgrade
P/TBV Ratio
1.381.231.451.240.570.99
Upgrade
P/FCF Ratio
5.224.68----
Upgrade
P/OCF Ratio
5.224.68----
Upgrade
EV/Sales Ratio
0.640.32----
Upgrade
EV/EBITDA Ratio
2.221.12----
Upgrade
EV/EBIT Ratio
2.261.14----
Upgrade
EV/FCF Ratio
1.510.76----
Upgrade
Debt / Equity Ratio
0.170.170.270.220.240.14
Upgrade
Debt / EBITDA Ratio
0.880.88----
Upgrade
Debt / FCF Ratio
0.630.63----
Upgrade
Net Debt / Equity Ratio
-0.98-0.98-0.92-0.91-0.82-0.93
Upgrade
Net Debt / EBITDA Ratio
-5.44-5.440.971.231.021.43
Upgrade
Net Debt / FCF Ratio
-3.71-3.711.231.591.111.76
Upgrade
Asset Turnover
0.530.53----
Upgrade
Quick Ratio
8.188.184.796.698.058.87
Upgrade
Current Ratio
8.428.424.926.828.379.12
Upgrade
Return on Equity (ROE)
22.88%22.88%-69.67%-70.94%-58.52%-49.87%
Upgrade
Return on Assets (ROA)
9.35%9.35%-35.02%-34.33%-28.73%-27.47%
Upgrade
Return on Capital Employed (ROCE)
15.60%15.60%-77.20%-62.20%-65.80%-56.60%
Upgrade
Earnings Yield
14.46%16.16%-57.54%-56.82%-139.28%-65.04%
Upgrade
FCF Yield
19.15%21.39%-51.45%-46.00%-130.27%-53.27%
Upgrade
Buyback Yield / Dilution
-4.61%-4.61%-25.19%-21.00%-0.38%-9.97%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.